Walter Ritter GmbH & Co   Report issue

For profit Phase 4
Founded: Hamburg Germany (1893)
Status: Acquired by Braun Beteiligungs GmbH (2009)

Organization Overview

First Clinical Trial
2009
NCT00975325
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Walter Ritter Pharmaceutica

Active Ingredients

Drugs in Phase 4 Trials (1)

yohimbine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erectile Dysfunction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1